Price (delayed)
$10.22
Market cap
$479.26M
P/E Ratio
15.72
Dividend/share
$0.04
EPS
$0.65
Enterprise value
$626.61M
Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70
Highlights
The stock's price to earnings (P/E) is 66% less than its 5-year quarterly average of 45.8 and 36% less than its last 4 quarters average of 24.7
CLB's net income is up by 25% year-on-year and by 6% since the previous quarter
The gross margin has decreased by 7% YoY
CLB's gross profit is down by 6% year-on-year
Key stats
What are the main financial stats of CLB
Market
Valuations
Earnings
Shares outstanding
46.89M
Market cap
$479.26M
Enterprise value
$626.61M
Price to earnings (P/E)
15.72
Price to book (P/B)
1.83
Price to sales (P/S)
0.92
EV/EBIT
11.8
EV/EBITDA
9.24
EV/Sales
1.21
Revenue
$517.38M
Gross profit
$101.2M
Operating income
$53.69M
Net income
$29.63M
EBIT
$53.1M
EBITDA
$67.83M
Free cash flow
$42.43M
Per share
Balance sheet
Liquidity
EPS
$0.65
EPS diluted
$0.64
Free cash flow per share
$0.91
Book value per share
$5.57
Revenue per share
$11.09
TBVPS
$10.64
Total assets
$602.11M
Total liabilities
$334.81M
Debt
$178.54M
Equity
$261.28M
Working capital
$132.91M
Debt to equity
0.68
Current ratio
2.27
Quick ratio
1.38
Net debt/EBITDA
2.17
Margins
Efficiency
Dividend
EBITDA margin
13.1%
Gross margin
19.6%
Net margin
5.7%
Operating margin
10.4%
Return on assets
5%
Return on equity
11.6%
Return on invested capital
9.7%
Return on capital employed
10.7%
Return on sales
10.3%
Dividend yield
0.39%
DPS
$0.04
Payout ratio
6.2%
CLB stock price
How has the Core Laboratories N V stock price performed over time
Intraday
-0.49%
1 week
-2.94%
1 month
-20.03%
1 year
-50.15%
YTD
-40.96%
QTD
-11.28%
Financial performance
How have Core Laboratories N V's revenue and profit performed over time
Revenue
$517.38M
Gross profit
$101.2M
Operating income
$53.69M
Net income
$29.63M
Gross margin
19.6%
Net margin
5.7%
CLB's net income is up by 25% year-on-year and by 6% since the previous quarter
CLB's net margin is up by 24% YoY and by 6% from the previous quarter
The gross margin has decreased by 7% YoY
CLB's gross profit is down by 6% year-on-year
Price vs fundamentals
How does CLB's price correlate with its fundamentals
Growth
What is Core Laboratories N V's growth rate over time
Valuation
What is Core Laboratories N V stock price valuation
P/E
15.72
P/B
1.83
P/S
0.92
EV/EBIT
11.8
EV/EBITDA
9.24
EV/Sales
1.21
The stock's price to earnings (P/E) is 66% less than its 5-year quarterly average of 45.8 and 36% less than its last 4 quarters average of 24.7
Core Laboratories N V's EPS has increased by 25% YoY and by 4.8% from the previous quarter
The P/B is 70% below the 5-year quarterly average of 6.2 and 37% below the last 4 quarters average of 2.9
CLB's equity is up by 9% YoY and by 3.1% from the previous quarter
CLB's price to sales (P/S) is 54% lower than its 5-year quarterly average of 2.0 and 34% lower than its last 4 quarters average of 1.4
Efficiency
How efficient is Core Laboratories N V business performance
The ROA has grown by 25% YoY and by 6% from the previous quarter
The return on equity rose by 13% year-on-year and by 2.7% since the previous quarter
The return on invested capital is up by 8% year-on-year
Dividends
What is CLB's dividend history
DPS
$0.04
Dividend yield
0.39%
Payout ratio
6.2%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Core Laboratories N V financials performed over time
The total assets is 80% greater than the total liabilities
The total liabilities has decreased by 4.9% YoY
CLB's current ratio is down by 5% year-on-year but it is up by 2.7% since the previous quarter
CLB's debt is 32% less than its equity
The debt to equity has decreased by 19% YoY and by 4.2% QoQ
CLB's debt is down by 11% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.